also on OXBT, The FDA may not even approve its ony drug by reverse merger. It may take another year even if it may get FDA approval.
NURO is the screaming, strong buy!
The Market will correct NURO to its fair value: minimal $10/share!
Strong buy especially if the general market crashes because there are way too many over-priced stocks and the general indecies.
NURO is a screaming buy!!!
The High estimate of NURO's market shares could be as high #$%$ Billion although NURO is trying to control the potential $11 B!!!!
NURO VS OXBT
NURO: 1.3 B and up
OXBI: 0.6B maximal
Market cap now
NURO: under $ 8M
OXBT: 0ver $30 M
NURO: sale will skyrocket
OXBT: still need approval. Less
NURO has 8M cash, profit next quarter!
The thing that really matters is NURO's sale will sky-rocket!
Strong buy !!!
I can guarantee that NURO will be over $ 10/share within the next few trading days.
With 8 M in Cash already in the bank with 2 new contracts signed. NURO will have net profit already.
I am confident that more and more contracts will be signed.
It is a nobrainer to buy and hold NURO.
There are two new contracts signed that was not in the revenue in the third quarter::
One on Sept 24, 2013 and another one on Oct 15, 2013.
Therefore, the next earning report will be up from the reported third quarter.
accelerated acceptance will bring more new contracts.
The only question is how big the sale will NURO gets
Am I wrong on something here?
Please correct me if you know it. I am still studying and analyzing this company to arrive at a fair valuation myself.
SENSUS: Markets: $300M. If NURO take a miminal $ 100M in sales/year, It translate into a market cap of $ 100M for NURO at the price of $ 30/share (just priced at very low 1X sae).
DPN Check: Markets: 11B. If NURO takes just a minimal of 1 B in sales/year, it translate into a market cap of $ 1B for NURO at the price of $ 300/share (just priced at a very low 1X sale).